GRP
DYN icon

Global Retirement Partners’s Dyne Therapeutics DYN Stock Holding History

Global Retirement Partners’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$71 Buy
+3
New +$89 ﹤0.01% 3563

Other funds holding DYN

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Global Retirement Partners's DYN Position: Q4 2024 in Review

Global Retirement Partners opened a new position in Dyne Therapeutics (DYN) in Q4 2024: 3 shares worth $71. The stake represents ﹤0.01% of the portfolio and ranks #3563 among its holdings.

200 funds tracked by Wall St. Rank hold DYN as of Q4 2024.

  • Global Retirement Partners held 3 shares of Dyne Therapeutics worth $71 as of Q4 2024.
  • Dyne Therapeutics was a new Global Retirement Partners position in Q4 2024.
  • Dyne Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2024, its #3563 holding.
  • 200 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q4 2024.

Based on Global Retirement Partners's 13F filing for Q4 2024, filed 31 Jan 2025.